Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
ECB’s Lagarde warns against premature inflation celebration
Post Content Post Views: 133
Stifel sees Boeing upside as new aircraft demand ‘remains very high’
Post Content Post Views: 116
Ituran Location GAAP EPS of $0.63 beats by $0.05, revenue of $81.1M
Post Content Post Views: 115
UiPath stock jumps 14% after ‘solid’ results
Post Content Post Views: 135
Black Friday shoppers spent a record $9.8 billion in U.S. online sales, up 7.5% from last year
Black Friday kept the momentum going from the day before on Thanksgiving when online sales totaled $5.6 billion. Post Views: 120
Congressmen ask SEC to probe Elon Musk over Neuralink comments: report
Post Content Post Views: 125